肝移植时代肝硬化门静脉高压症的外科治疗  

Surgery for cirrhotic portal hypertension in the era of liver transplantation

作　　者：朱继业[1] 倪彦彬[1] Zhu Jiye;Ni Yanbin(Department of Hepatobiliary Surgery,Peking University People’s Hospital,Key Basic Research Laboratory of Liver Cirrhosis and Liver Cancer,Beijing 100044,China)

机构地区：[1]北京大学人民医院肝胆外科肝硬化肝癌基础研究北京市重点实验室,100044

出　　处：《中华肝胆外科杂志》2021年第1期4-7,共4页Chinese Journal of Hepatobiliary Surgery

摘　　要：肝移植是肝硬化门静脉高压症的唯一根治手段,尤其对于合并肝功能衰竭的门静脉高压症患者。在肝移植时代,对于药物、内镜、介入等治疗无效的门静脉高压症食管胃底曲张静脉破裂出血患者,外科治疗(除肝移植外)的地位依然无可替代,既要针对患者的自身情况制定个体化手术方案,也要尽可能减少患者今后可能行肝移植手术的难度及风险。Liver transplantation is the only curative treatment for cirrhotic portal hypertension,especially for the patients with end-stage liver failure.In the era of liver transplantation,when drugs,endoscopy and interventional treatments fail,surgery(not including liver transplantation)is an irreplaceable treatment option for esophagogastric variceal bleeding,which should be individualized,in order not to increase the risk and difficulty of liver transplantation in the future.

关 键 词：肝硬化 门静脉高压症 食管胃底曲张静脉破裂出血 门静脉血栓 肝移植 

分 类 号：R657.3[医药卫生—外科学]